Cargando…

‘Never change a winning team’: GPs’ perspectives on discontinuation of long-term antidepressants

BACKGROUND: Long-term antidepressant use, much longer than recommended by guidelines, can harm patients and generate unnecessary costs. Most antidepressants are prescribed by general practitioners (GPs) but it remains unclear why they do not discontinue long-term use. AIM: To explore GPs’ views and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellen, Van Leeuwen, Anthierens, Sibyl, van Driel, Mieke L., Sutter, An De, van den Branden, Evelien, Christiaens, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725864/
https://www.ncbi.nlm.nih.gov/pubmed/34895003
http://dx.doi.org/10.1080/02813432.2021.2006487
_version_ 1784626201742016512
author Ellen, Van Leeuwen
Anthierens, Sibyl
van Driel, Mieke L.
Sutter, An De
van den Branden, Evelien
Christiaens, Thierry
author_facet Ellen, Van Leeuwen
Anthierens, Sibyl
van Driel, Mieke L.
Sutter, An De
van den Branden, Evelien
Christiaens, Thierry
author_sort Ellen, Van Leeuwen
collection PubMed
description BACKGROUND: Long-term antidepressant use, much longer than recommended by guidelines, can harm patients and generate unnecessary costs. Most antidepressants are prescribed by general practitioners (GPs) but it remains unclear why they do not discontinue long-term use. AIM: To explore GPs’ views and experiences of discontinuing long-term antidepressants, barriers and facilitators of discontinuation and required support. DESIGN AND SETTING: Qualitative study in Belgian GPs. METHOD: 20 semi-structured face-to-face interviews with GPs. Interviews were analysed thematically. RESULTS: The first theme, ‘Success stories’ describes three strong motivators to discontinue antidepressants: patient health issues, patient requests and a new positive life event. Second, not all GPs consider long-term antidepressant use a ‘problem’ as they perceive antidepressants as effective and safe. GPs’ main concern is the risk of relapse. Third, GPs foresee that discontinuation of antidepressants is not an easy and straightforward process. GPs weigh up whether they have the necessary skills and whether it is worth the effort to start this process. CONCLUSION: Discontinuation of long-term antidepressants is a difficult and uncertain process for GPs, especially in the absence of a facilitating life-event or patient demand. The absence of a compelling need for discontinuation and fear of relapse of symptoms in a stable patient are important barriers for GPs when considering discontinuation. In order to increase GPs’ motivation to discontinue long-term antidepressants, more emphasis on the futility of the actual effect and on potential harms related to long-term use is needed. KEY POINTS: Current awareness: Long-term antidepressant use, much longer than recommended by guidelines, can harm patients and generate unnecessary costs. Main statements:  • Discontinuation of long-term antidepressants is a difficult and uncertain process for GPs.  • More emphasis on the futility of the actual effect of antidepressants and on potential harms related to long-term use is needed.
format Online
Article
Text
id pubmed-8725864
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-87258642022-01-05 ‘Never change a winning team’: GPs’ perspectives on discontinuation of long-term antidepressants Ellen, Van Leeuwen Anthierens, Sibyl van Driel, Mieke L. Sutter, An De van den Branden, Evelien Christiaens, Thierry Scand J Prim Health Care Original Articles BACKGROUND: Long-term antidepressant use, much longer than recommended by guidelines, can harm patients and generate unnecessary costs. Most antidepressants are prescribed by general practitioners (GPs) but it remains unclear why they do not discontinue long-term use. AIM: To explore GPs’ views and experiences of discontinuing long-term antidepressants, barriers and facilitators of discontinuation and required support. DESIGN AND SETTING: Qualitative study in Belgian GPs. METHOD: 20 semi-structured face-to-face interviews with GPs. Interviews were analysed thematically. RESULTS: The first theme, ‘Success stories’ describes three strong motivators to discontinue antidepressants: patient health issues, patient requests and a new positive life event. Second, not all GPs consider long-term antidepressant use a ‘problem’ as they perceive antidepressants as effective and safe. GPs’ main concern is the risk of relapse. Third, GPs foresee that discontinuation of antidepressants is not an easy and straightforward process. GPs weigh up whether they have the necessary skills and whether it is worth the effort to start this process. CONCLUSION: Discontinuation of long-term antidepressants is a difficult and uncertain process for GPs, especially in the absence of a facilitating life-event or patient demand. The absence of a compelling need for discontinuation and fear of relapse of symptoms in a stable patient are important barriers for GPs when considering discontinuation. In order to increase GPs’ motivation to discontinue long-term antidepressants, more emphasis on the futility of the actual effect and on potential harms related to long-term use is needed. KEY POINTS: Current awareness: Long-term antidepressant use, much longer than recommended by guidelines, can harm patients and generate unnecessary costs. Main statements:  • Discontinuation of long-term antidepressants is a difficult and uncertain process for GPs.  • More emphasis on the futility of the actual effect of antidepressants and on potential harms related to long-term use is needed. Taylor & Francis 2021-12-11 /pmc/articles/PMC8725864/ /pubmed/34895003 http://dx.doi.org/10.1080/02813432.2021.2006487 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Ellen, Van Leeuwen
Anthierens, Sibyl
van Driel, Mieke L.
Sutter, An De
van den Branden, Evelien
Christiaens, Thierry
‘Never change a winning team’: GPs’ perspectives on discontinuation of long-term antidepressants
title ‘Never change a winning team’: GPs’ perspectives on discontinuation of long-term antidepressants
title_full ‘Never change a winning team’: GPs’ perspectives on discontinuation of long-term antidepressants
title_fullStr ‘Never change a winning team’: GPs’ perspectives on discontinuation of long-term antidepressants
title_full_unstemmed ‘Never change a winning team’: GPs’ perspectives on discontinuation of long-term antidepressants
title_short ‘Never change a winning team’: GPs’ perspectives on discontinuation of long-term antidepressants
title_sort ‘never change a winning team’: gps’ perspectives on discontinuation of long-term antidepressants
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725864/
https://www.ncbi.nlm.nih.gov/pubmed/34895003
http://dx.doi.org/10.1080/02813432.2021.2006487
work_keys_str_mv AT ellenvanleeuwen neverchangeawinningteamgpsperspectivesondiscontinuationoflongtermantidepressants
AT anthierenssibyl neverchangeawinningteamgpsperspectivesondiscontinuationoflongtermantidepressants
AT vandrielmiekel neverchangeawinningteamgpsperspectivesondiscontinuationoflongtermantidepressants
AT sutterande neverchangeawinningteamgpsperspectivesondiscontinuationoflongtermantidepressants
AT vandenbrandenevelien neverchangeawinningteamgpsperspectivesondiscontinuationoflongtermantidepressants
AT christiaensthierry neverchangeawinningteamgpsperspectivesondiscontinuationoflongtermantidepressants